DE3137125A1 - Verwendung von pyridoxin-(alpha)-ketoglutarat fuer die prophylaxe der hyperlactacidaemie - Google Patents
Verwendung von pyridoxin-(alpha)-ketoglutarat fuer die prophylaxe der hyperlactacidaemieInfo
- Publication number
- DE3137125A1 DE3137125A1 DE19813137125 DE3137125A DE3137125A1 DE 3137125 A1 DE3137125 A1 DE 3137125A1 DE 19813137125 DE19813137125 DE 19813137125 DE 3137125 A DE3137125 A DE 3137125A DE 3137125 A1 DE3137125 A1 DE 3137125A1
- Authority
- DE
- Germany
- Prior art keywords
- ketoglutarate
- pyridoxine
- toxic
- prophylaxis
- pak
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT24827/80A IT1141070B (it) | 1980-09-22 | 1980-09-22 | Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3137125A1 true DE3137125A1 (de) | 1982-04-01 |
| DE3137125C2 DE3137125C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-04-06 |
Family
ID=11214855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19813137125 Granted DE3137125A1 (de) | 1980-09-22 | 1981-09-18 | Verwendung von pyridoxin-(alpha)-ketoglutarat fuer die prophylaxe der hyperlactacidaemie |
Country Status (12)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| DK1169322T3 (da) | 1999-03-08 | 2006-03-06 | Medicure Inc | Pyridoxalanaloger til behandling af lidelser foranlediget af vitamin B6-mangel |
| AU5840200A (en) * | 1999-07-13 | 2001-01-30 | Medicure Inc. | Treatment of diabetes and related pathologies |
| EP1210117A2 (en) * | 1999-08-24 | 2002-06-05 | Medicure International Inc. | Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| ATE293119T1 (de) | 2000-02-29 | 2005-04-15 | Medicure Int Inc | Cardioprotektive phosphonate |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| JP2003528146A (ja) | 2000-03-28 | 2003-09-24 | メディキュア インターナショナル インコーポレイテッド | 脳血管疾患の治療 |
| US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| NZ523815A (en) | 2000-07-07 | 2004-07-30 | Medicure Int Inc | Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
| US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| US7459468B2 (en) | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| JP2008517956A (ja) | 2004-10-28 | 2008-05-29 | メディキュア・インターナショナル・インコーポレーテッド | 二重の抗血小板性／抗凝固性ピリドキシン類似体 |
| US20090156648A1 (en) * | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA) |
| WO2009073944A1 (en) * | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION |
| US10278327B2 (en) | 2014-05-09 | 2019-05-07 | Shakespeare Company, Llc | Trimmer head for use with line and blades |
| WO2020086733A1 (en) * | 2018-10-24 | 2020-04-30 | Ponce De Leon Health Designated Activity Company | Nicotinamide riboside compositions for healthspan extension |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1958226A1 (de) * | 1968-11-22 | 1970-05-27 | Made Labor Sa | Pyridoxin-alpha-ketoglutarat |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6453M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1967-06-13 | 1968-11-12 | ||
| US3784553A (en) * | 1972-01-17 | 1974-01-08 | Made Labor Sa | Pyridoxine alpha-ketoglutarate and its derivatives |
-
1980
- 1980-09-22 IT IT24827/80A patent/IT1141070B/it active
-
1981
- 1981-09-08 US US06/300,202 patent/US4361570A/en not_active Expired - Fee Related
- 1981-09-09 ZA ZA816242A patent/ZA816242B/xx unknown
- 1981-09-10 CA CA000385576A patent/CA1177408A/en not_active Expired
- 1981-09-18 DE DE19813137125 patent/DE3137125A1/de active Granted
- 1981-09-18 GB GB8128222A patent/GB2084018A/en not_active Withdrawn
- 1981-09-21 SE SE8105561A patent/SE459899B/sv not_active IP Right Cessation
- 1981-09-21 FR FR8117789A patent/FR2490493B1/fr not_active Expired
- 1981-09-22 CH CH6112/81A patent/CH655009A5/it not_active IP Right Cessation
- 1981-09-22 BE BE0/206032A patent/BE890454A/fr not_active IP Right Cessation
- 1981-09-22 JP JP56148922A patent/JPS5782316A/ja active Pending
- 1981-09-22 NL NL8104357A patent/NL8104357A/nl not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1958226A1 (de) * | 1968-11-22 | 1970-05-27 | Made Labor Sa | Pyridoxin-alpha-ketoglutarat |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5782316A (en) | 1982-05-22 |
| IT1141070B (it) | 1986-10-01 |
| FR2490493B1 (fr) | 1986-03-07 |
| FR2490493A1 (fr) | 1982-03-26 |
| CA1177408A (en) | 1984-11-06 |
| DE3137125C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-04-06 |
| NL8104357A (nl) | 1982-04-16 |
| SE8105561L (sv) | 1982-03-23 |
| US4361570A (en) | 1982-11-30 |
| IT8024827A0 (it) | 1980-09-22 |
| ZA816242B (en) | 1982-08-25 |
| SE459899B (sv) | 1989-08-21 |
| GB2084018A (en) | 1982-04-07 |
| BE890454A (fr) | 1982-01-18 |
| CH655009A5 (it) | 1986-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3137125C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2813480C2 (de) | Arzneimittel-Depotpräparat vom Mehrfacheinheitsdosen-Typ | |
| DE69533940T2 (de) | Therapeutische zusammensetzungen von venösdilatoren und arterielldilatoren | |
| CH653891A5 (de) | Mittel fuer die orale verabreichung an einen menschen und/oder ein saeugetier. | |
| EP0185210B1 (de) | Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten | |
| DE3883606T2 (de) | Verwendung von Fluoxetin zur Behandlung des Diabetes. | |
| DE3119460A1 (de) | Pharmazeutische zusammensetzung aus l-karnitin und/oder l-acylkarnitin und verwendung der zusammensetzung gegen diabetes mellitus bei jugendlichen | |
| EP0689837B1 (de) | Antihyperglykämisch wirksame Arzneimittel | |
| DE2513940A1 (de) | Pharmazeutische zubereitung | |
| DE68915269T2 (de) | Polyvalentes entzündungshemmendes mittel. | |
| DE3504933C2 (de) | Arzneimittel zur Behandlung von Diabetes und Leberfunktionsstörungen | |
| DE2530862C2 (de) | Verwendung von Uridin-5'-diphosphat zur Verhütung und Behandlung von Alkoholismus | |
| EP1001756B1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
| DE69910600T2 (de) | Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist | |
| DE69525348T2 (de) | Medikament gegen myotonische dystrophie | |
| DE2640322A1 (de) | Medizinische zubereitung mit einem gehalt an nebennierenrindenhormon und einem ein schilddruesenstimulierendes hormon freisetzenden hormon | |
| DE2445801A1 (de) | Arzneimittel zur behandlung von diabetischer ketoacidose | |
| DE4124481A1 (de) | Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten | |
| DE69115102T2 (de) | Stabilisator für eine 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide enthaltende Zusammensetzung und Stabilisierungsverfahren. | |
| DE68905424T2 (de) | Alpha-glucosidaseinhibitor zur foerderung der calciumabsorption. | |
| DE3115322A1 (de) | Oral zu verabreichendes, pharmazeutisch bzw. diagnostisch oder als nahrungsmittelzusatz wirksames bzw. verwendbares mittel | |
| DE2823268C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| EP0018550B1 (de) | Mittel zur Behandlung von Muskelerkrankungen | |
| DE3904795C2 (de) | Pharmazeutisches Präparat und dessen Verwendung | |
| DE3213579C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8128 | New person/name/address of the agent |
Representative=s name: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |